Pylorus‐Preserving Gastrectomy for Gastric Cancer: Current Evidence and Future Directions Authors: Sa‐Hong Kim, Hyuk‐Joon Lee Published: 2026 ABSTRACT ABSTRACTPylorus‐preserving gastrectomy (PPG) is a function‐preserving surgery for clinically T1N0M0 (cT1N0M0) early gastric cancer (EGC) located in the middle third of the stomach, at least 4 cm proximal from the pylorus. By preserving the peri‐pyloric tissues, including the hepatic branch of the vagus nerve and the infrapyloric vessels, PPG maintains physiological pyloric function without compromising oncologic safety. Several randomized controlled trials (RCTs) have demonstrated the functional advantages of PPG. In particular, the Korean multicenter RCT (KLASS‐04) reported a lower incidence of gallstone formation, bile reflux, and postoperative nutritional deficiencies. While PPG is technically demanding and associated with concerns regarding delayed gastric emptying (DGE), recent advances in minimally invasive surgery and intraoperative assessment tools, including augmented imaging technology using indocyanine green (ICG), have facilitated its safe implementation. Although PPG is currently indicated for cT1N0M0 EGC, emerging evidence suggests that patients pathologically confirmed as advanced disease postoperatively may still achieve favorable outcomes with standard adjuvant therapy without requiring additional surgery, suggesting potential oncological acceptability of PPG in carefully selected patients with advanced disease. The integration of robotic platforms and navigation‐guided visualization with augmented imaging technology may further enhance oncologic safety and technical feasibility. This review aims to outline the current evidence and future directions of PPG, focusing on the feasibility of extending its application beyond its traditional indications. Introduction Nationwide gastric cancer screening programs in Japan and Korea have led to early diagnosis, resulting in improved clinical outcomes [1, 2, 3]. Given the favorable prognosis of early gastric cancer (EGC), pylorus‐preserving gastrectomy (PPG) offers a balance between oncologic radicality and the preservation of physiological function [4]. PPG was first performed for gastric ulcer treatment [5], and was noted to reduce the frequency of postoperative complications associated with conventional distal or total gastrectomy, such as dumping syndrome, bile reflux esophagitis, and nutritional deficiencies [4]. These advantages are attributed to the preservation of the hepatic branch of the vagus nerve and the maintenance of infrapyloric blood supply to the pylorus and antral cuff [6, 7]. Consequently, PPG has been recommended as a standard procedure for cT1N0M0 EGC patients who meet specific criteria, with its oncologic safety and functional advantages more objectively validated by several randomized controlled trials (RCTs), particularly from East Asian countries, including South Korea [6, 8, 9]. Meanwhile, recent emerging evidence suggests that patients confirmed as having advanced gastric cancer (AGC) postoperatively may still achieve a favorable prognosis when treated with standard adjuvant chemotherapy without requiring completion surgery [10]. The growing use of minimally invasive surgical techniques, including laparoscopic and robotic surgery [11, 12, 13, 14, 15, 16] combined with advances in intraoperative assessment modalities such as gastroscopy [17] and indocyanine green (ICG) fluorescence‐navigated imaging, a near‐infrared fluorescence technique used to visualize blood flow or lymphatic drainage during surgery [18], has further enhanced the oncologic safety and technical feasibility of PPG, and is expected to broaden its future indications and clinical applicability of PPG. While previous studies have addressed specific aspects of PPG, comprehensive reviews incorporating recent evidence and emerging technologies remain limited. This review provides a comprehensive overview of PPG, focusing on preoperative considerations, surgical techniques, and functional and oncologic outcomes. In addition, it further explores the potential expansion of PPG indications beyond EGC to selected AGC cases, supported by robotic platforms and navigation‐guided visualization with augmented imaging technology. Preoperative Considerations for PPG: Indications According to the Korean and Japanese Gastric Cancer Treatment Guidelines, PPG is indicated for cT1N0M0 EGC located in the middle third of the stomach, provided that the distal end of the tumor is at least 4 cm away from the pylorus to ensure both function preservation and oncological safety [19, 20]. Firstly, in terms of function preservation, minimizing manipulation around the pylorus is crucial. The right gastric artery, which supplies the suprapyloric area (lymph node station number 5; LN#5), runs alongside the pyloric branch of the vagus nerve. Earlier studies demonstrated that shorter antral cuffs are associated with higher rates of delayed gastric emptying (DGE) [21], while preserving an approximately 2‐cm suprapyloric buffer zone without direct manipulation helps prevent nerve injury and maintain pyloric function. Secondly, in terms of oncologic safety, PPG requires balancing meticulous infrapyloric lymph node dissection (LN#6) with the preservation of the infrapyloric vessels. LN#5 dissection was typically omitted in PPG, supported by evidence showing a low therapeutic index in middle third gastric cancer (LN#5: 0.8 vs. LN#6: 3.9) [22], in which the therapeutic index represents the product of metastatic frequency and the survival benefit of lymph node dissection, and a low incidence of lymphatic spread to LN#5 in appropriately selected patients (LN#5: 0% vs. LN#6: 0.7%, for cT1‐3 N0/1 M0) [23]. Unlike LN#5, meticulous LN#6 dissection remains mandatory [24], but preservation of the infrapyloric vessels inevitably raises concerns about incomplete lymph node dissection. Therefore, PPG is only to be indicated for cT1N0M0 to ensure limited lymphatic spread to LN#5 and LN#6. Preoperative Evaluation for Optimizing the Surgical Plan Japanese criteria recommended a minimum distance of 4 cm from the pylorus to the distal end of the tumor [15], and subsequent evidence in Korea suggested a refined criterion [24]. Preoperative gastroscopy is essential for the accurate assessment of tumor location and extent [25], and for marking the tumor margins with metal clips. This procedure facilitates optimal surgical planning, while intraoperative gastroscopy further provides real‐time confirmation of the tumor margins and the gastric transection line [17]. Contrast‐enhanced CT is a fundamental preoperative study for gastric cancer patients, providing information on tumor extent, regional nodal status, and distant metastasis [26]. Endoscopic ultrasonography (EUS) is helpful for assessing the depth of invasion and perigastric nodal involvement [27], though its diagnostic accuracy varies across studies, with reported understaging rates of approximately 7.4%–10% [10, 28]. Therefore, the combined use of CT and EUS is recommended to improve overall preoperative staging accuracy. Surgical Techniques for PPG: Preservation of the Pylorus PPG starts with an omentectomy, followed by lymph node dissection with ligation of the left and right gastroepiploic vessels (LN#4sb and LN#4d). Careful dissection is mandatory to preserve the infrapyloric vessels at the LN#6 area. A Japanese anatomical study reported that the infrapyloric artery (IPA) arises from one of three sources: The gastroduodenal artery (proximal type, 12.7%), the anterior superior pancreatoduodenal artery (distal type, 64.2%), or the right gastroepiploic artery (caudal type, 23.1%) [29]. A Chinese observational study reported IPA origins as proximal (36.8%), distal (31.0%), and caudal (27.2%) [30]. In a post hoc analysis of a Korean multicenter RCT, the distribution was proximal (38.0%), distal (23.4%), and caudal (38.5%) [31]. Therefore, the ligation point of the right gastroepiploic artery root depends on the origin of the IPA. The suprapyloric area (LN#5) should be handled cautiously to avoid injuries to the hepatic branch of the vagus nerve; therefore, the right gastric vessels are ligated after branching off the first or second arcade. LN#7, #8a, #9, and optionally #11p, are dissected with ligation of the coronary vein and the left gastric artery. Since the hepatic branch of the vagus nerve usually originates above the gastroesophageal junction (GEJ), the right paracardial LN (LN#1) can be adequately dissected at or below the GEJ level without sacrificing this nerve branch [32], followed by dissection of the lesser curvature LNs (LN#3a and 3b). Adequate antral cuff and resection margins from the tumor are confirmed by intraoperative frozen biopsy [33] to optimize sufficient remnant stomach volume [34]. Extracorporeal gastro‐gastrostomy is typically performed with a hand‐sewn, end‐to‐end anastomosis, which re‐establishes continuity between the proximal and distal gastric remnants [35]. Similar to an intracorporeal delta‐shaped gastroduodenostomy in laparoscopic DG, a triangular stapled anastomosis technique widely used in minimally invasive gastrectomy [36], an intracorporeal delta‐shaped gastro‐gastrostomy [37, 38], and another intracorporeal variation known as the ‘piercing method’ have been adopted in clinical practice [39]. An overview of the surgical procedure, including preservation of the hepatic branch of the vagus nerve and the infrapyloric artery, and perigastric lymph node dissection, is illustrated in Figure 1. Surgical procedure of pylorus‐preserving gastrectomy (PPG). (A) Preservation of the hepatic branch of the vagus nerve and the infrapyloric artery during perigastric lymph node dissection (green‐shaded area). (B) Configuration of the stomach after resection of the middle third of the stomach. Surgical Advantages By preserving the pyloric sphincter, PPG enables a more gradual and regulated passage of food, reducing rapid transit symptoms often observed in other types of gastrectomy [4]. The oncologic feasibility of PPG has been supported by a meta‐analysis [40] and a Korean multicenter prospective RCT [8], both demonstrating no significant differences in complication or recurrence rates compared to DG. Key advantages of PPG include reduced postoperative complications, improved gastrointestinal function, favorable nutritional outcomes, and enhanced quality of life. These benefits are closely interrelated and mutually reinforcing, warranting a comprehensive assessment with an integrated perspective. Postoperative Complications Overall postoperative outcomes after PPG are favorable compared with DG, although DGE remains an important functional concern. Multiple studies have demonstrated that PPG provides better functional outcomes, including less body weight loss, reduced bile reflux, lower incidence of anastomosis leakage [40, 41], lower rates of dumping syndrome [42], and less gallstone formation [8] compared to DG. DGE is often diagnosed based on clinical manifestations such as postprandial epigastric fullness, dyspepsia, or early satiety, supported by imaging modalities including a plain radiography or an upper gastrointestinal series (UGIS). During the early experience with PPG, the reported incidence of DGE was as high as 40% [43]. More recent series of papers have shown substantially lower rates ranging from 5.6% to 21.6% [44, 45, 46, 47]. In a Japanese retrospective study, early postoperative gastric stasis (E‐stasis) was associated with age, diabetes mellitus, and postoperative intra‐abdominal infection. Late postoperative food residue (L‐residue) at 1 year postoperatively was associated with male sex, age, diabetes mellitus, body mass index (BMI), and antecedent E‐stasis [48]. In addition to patient factors, several surgical contributors to DGE after PPG have been reported, including injuries to the hepatic branch of the vagus nerve, the infrapyloric artery [44], the infrapyloric vein [49], and a short antral cuff length [21]. In a Korean RCT, these surgical contributors were effectively minimized through procedure standardization and surgeon qualification, yet DGE still occurred more frequently after PPG than DG (16.3% vs. 3.9%, p = 0.001) [8]. In a secondary analysis of the same trial, a prior history of abdominal surgery was the only factor associated with a reduced risk of DGE (p = 0.026), suggesting that less manipulation during surgery may contribute to better postoperative gastric motility [50]. Another analysis from the same cohort demonstrated that IPA anatomy itself was not associated with DGE [31]. As a preventive measure, gentle intraoperative manual dilation of the pylorus has been associated with a lower rate of early stasis [51], and several therapeutic interventions have been reported for pyloric dysfunction after PPG. Bae et al. [52] demonstrated significant improvements in symptom scores and in the pyloric canal‐to‐vertebral height ratio after initial balloon dilatation (BD) (p < 0.001, retrospectively). In another retrospective study, first‐line BD showed a success rate of 41.7% [53]. Botulinum toxin injection into the pylorus has been reported to be an effective method for symptom relief [54]. Gastric per‐oral endoscopic myotomy (G‐POEM) has recently emerged as a minimally invasive alternative, showing comparable outcomes to surgical pyloroplasty [55]. In addition, in an investigational porcine model, Park et al. evaluated the role of temporary biodegradable pyloric stents for maintaining temporary pyloric patency after PPG [56] (Table 1). TABLE 1Summary of Delayed Gastric Emptying (DGE) after Pylorus‐Preserving Gastrectomy (PPG). Summary of literature evaluating the incidence, risk factors, surgical contributors, and prevention or treatment strategies for DGE following PPG.CategoryAuthor (Year)Study PeriodNumber of CasesStudy designKey FindingsMain outcomes; N (%) or others p IncidenceTomita R, et al. (2003)1993–1996 PPG 10 DG 22 Retrospective Endoscopic gastric stasis; Higher in PPG PPG vs. DG 4 (40.0) vs. 6 (27.3) 0.018Nunobe S, et al. (2007)1993–2000 PPG 194 DG 203 Retrospective Endoscopic gastric stasis; Higher in PPG PPG vs. DG 42 (21.6) vs. 27 (13.3) 0.028Morita S, et al. (2008)1995–2004PPG 611Retrospective (single‐arm)Overall DGE incidence after PPG49 (8.0)—Tanaka N, et al. (2011)2006–2009 LAPPG 90 OPPG 90 RetrospectiveComparable DGE LAPPG vs. OPPG 6 (6.7) vs. 5 (5.6) N.S Jiang X, et al. (2011)2005–2009PPG 1026Retrospective (single‐arm)Low DGE incidence in a high‐volume cohort19 (6.3)—Risk factorsTakahashi R, et al. (2020)2005–2017LPPG 897Retrospective HR (95% CI) Early postoperative gastric stasis (E‐stasis) 68 (7.6) Age ≥ 61 1.70 (1.02–2.83) 0.042 Diabetes 2.84 (1.13–7.15) 0.026 Postoperative intra‐abdominal infection 3.56 (1.92–6.60) < 0.001 HR (95% CI) Late postoperative food residue (L‐residue) 28/62 (45.2) Male sex 1.49 (1.06–2.09) 0.019 Age ≥ 61 1.50 (1.10–2.05) 0.011 BMI ≥ 20.9 1.82 (1.27–2.60) 0.001 Antecedent E‐stasis 2.53 (1.47–4.37) < 0.001Surgical contributorsNunobe S, et al. (2007)2003–2006 LAPPG 39 OPPG 51 RetrospectiveLow DGE After preservation of the pyloric branch of the vagus nerve and the infrapyloric artery LAPPG 3 (8.0) OPPG 3 (6.0) 1.000Kiyokawa T, et al. (2017)2011–2013 PPG 150; IPV preserved 56 IPV Not preserved 94 Retrospective Low DGE after preservation of IPV Preserved vs. not preserved 0 (0.0) vs. 8 (8.5) 0.03Nakane Y, et al. (2002)1993–1999 PPG 30; Antral cuff, 1.5 cm 20 Antral cuff, 2.5 cm 10 RetrospectiveLow DGE after a longer antral cuff 1.5 cm vs. 2.5 cm 11 (55.0) vs. 1 (10.0) < 0.05Rhee YS, et al. (2025)2015–2017 PPG 124; DGE 21 Non‐DGE 103 KLASS‐04 RCT secondary analysis Prior abdominal surgery Lower DGE risk OR 0.094 95% CI 0.012–0.757 0.026Eom SS, et al. (2025)2015–2017 PPG 119; Proximal type 41 Distal type 30 Caudal type 48 KLASS‐04 RCT secondary analysis IPA anatomical pattern; Not associated with morbidity Proximal type 6 (14.6%) Distal type 8 (26.7%) Caudal type 8 (17%) 0.409Prevention/TreatmentZhu CC, et al. (2018)2014–2016 PPG 232; Intraoperative manual dilatation 93 No dilatation 130 Retrospective Lower early stasis after intraoperative pyloric manual dilatation Dilatation vs. not done 1 (1.1) vs. 12 (8.6) 0.019Bae JS, et al. (2015)2008–2014 PPG 732; Pyloric stenosis 47; BD 33 Retrievable stent after BD failure 12 RetrospectiveBD is effective for pyloric stenosis (1st line) Symptom score 8.8 → 1.7 < 0.001 Ratio of pyloric canal to height of vertebral body 7.2 → 25.4 < 0.001A stent is effective after BD failure Symptom score 9.8 → 2.7 0.002 Ratio of pyloric canal to height of vertebral body 5.8 → 26.9 0.002Lim HT, et al. (2020)2013–2017 PPG 677; 1st line BD 48 2nd line BD 11 Retrievable stent after 1st line BD 17 RetrospectiveA stent is effective after 1st line BD failure Success rate — 1st line BD 41.7% (20 of 48) 2nd line BD 45.5% (5 of 11) Stent 100% (17 of 17) Lee JH, et al. (2017)2012–2015 PPG 177; DGE 13; Conservative 7 Botulinum toxin injection 6 RetrospectiveEndoscopic botulinum toxin injection is effective for DGE reliefGastric Outlet Obstruction Scoring System (GOOSS) improved at the postoperative 10th day—Eriksson SE, et al. (2025)2013–2023 Laparoscopic pyloroplasty 233 G‐POEM 81 RetrospectiveComparable symptom resolution, length of stay, readmission, complicationsGastroparesis cardinal symptom index (GCSI)0.624Length of stay0.129Readmission1.000Complication1.000Park JH, et al. (2023)2020 Biodegradable scaffold stents, porcine model 10; PGCL stent 4 PPDO stent 4 No stent 2 Investigational PGCL stent; fast degradation, rapid recovery of GI symptoms PPDO stent; persisted longer with more GI symptoms PGCL dissolved POD 8–10 PPDO remained to POD13 —Abbreviations: BD, balloon dilatation; BMI, body mass index; CI, confidence interval; G‐POEM, gastric per‐oral endoscopic myotomy; HR, hazard ratio; IPA, infrapyloric artery; IPV, infrapyloric vein; LAPPG, laparoscopy‐assisted pylorus‐preserving gastrectomy; N.S, not significant; OPPG, open pylorus‐preserving gastrectomy; OR, odds ratio; PGCL, poly(glycolide‐co‐caprolactone)(Vicryl); PPDO, polydioxanone (PDS II). Summary of Delayed Gastric Emptying (DGE) after Pylorus‐Preserving Gastrectomy (PPG). Summary of literature evaluating the incidence, risk factors, surgical contributors, and prevention or treatment strategies for DGE following PPG. PPG 10 DG 22 Endoscopic gastric stasis; Higher in PPG PPG vs. DG 4 (40.0) vs. 6 (27.3) PPG 194 DG 203 Endoscopic gastric stasis; Higher in PPG PPG vs. DG 42 (21.6) vs. 27 (13.3) LAPPG 90 OPPG 90 LAPPG vs. OPPG 6 (6.7) vs. 5 (5.6) Early postoperative gastric stasis (E‐stasis) 68 (7.6) Age ≥ 61 1.70 (1.02–2.83) Diabetes 2.84 (1.13–7.15) Postoperative intra‐abdominal infection 3.56 (1.92–6.60) Late postoperative food residue (L‐residue) 28/62 (45.2) Male sex 1.49 (1.06–2.09) Age ≥ 61 1.50 (1.10–2.05) BMI ≥ 20.9 1.82 (1.27–2.60) Antecedent E‐stasis 2.53 (1.47–4.37) LAPPG 39 OPPG 51 LAPPG 3 (8.0) OPPG 3 (6.0) PPG 150; IPV preserved 56 IPV Not preserved 94 Low DGE after preservation of IPV Preserved vs. not preserved 0 (0.0) vs. 8 (8.5) PPG 30; Antral cuff, 1.5 cm 20 Antral cuff, 2.5 cm 10 1.5 cm vs. 2.5 cm 11 (55.0) vs. 1 (10.0) PPG 124; DGE 21 Non‐DGE 103 Prior abdominal surgery Lower DGE risk OR 0.094 95% CI 0.012–0.757 PPG 119; Proximal type 41 Distal type 30 Caudal type 48 IPA anatomical pattern; Not associated with morbidity Proximal type 6 (14.6%) Distal type 8 (26.7%) Caudal type 8 (17%) PPG 232; Intraoperative manual dilatation 93 No dilatation 130 Lower early stasis after intraoperative pyloric manual dilatation Dilatation vs. not done 1 (1.1) vs. 12 (8.6) PPG 732; Pyloric stenosis 47; BD 33 Retrievable stent after BD failure 12 Symptom score 8.8 → 1.7 Ratio of pyloric canal to height of vertebral body 7.2 → 25.4 Symptom score 9.8 → 2.7 Ratio of pyloric canal to height of vertebral body 5.8 → 26.9 PPG 677; 1st line BD 48 2nd line BD 11 Retrievable stent after 1st line BD 17 1st line BD 41.7% (20 of 48) 2nd line BD 45.5% (5 of 11) Stent 100% (17 of 17) PPG 177; DGE 13; Conservative 7 Botulinum toxin injection 6 Laparoscopic pyloroplasty 233 G‐POEM 81 Biodegradable scaffold stents, porcine model 10; PGCL stent 4 PPDO stent 4 No stent 2 PGCL stent; fast degradation, rapid recovery of GI symptoms PPDO stent; persisted longer with more GI symptoms PGCL dissolved POD 8–10 PPDO remained to POD13 Abbreviations: BD, balloon dilatation; BMI, body mass index; CI, confidence interval; G‐POEM, gastric per‐oral endoscopic myotomy; HR, hazard ratio; IPA, infrapyloric artery; IPV, infrapyloric vein; LAPPG, laparoscopy‐assisted pylorus‐preserving gastrectomy; N.S, not significant; OPPG, open pylorus‐preserving gastrectomy; OR, odds ratio; PGCL, poly(glycolide‐co‐caprolactone)(Vicryl); PPDO, polydioxanone (PDS II). Nutrition Functional preservation after PPG is reflected in improved postoperative nutritional status. By preserving gastric acid and gastrin secretion and maintaining the physiological duodenal passage, PPG supports efficient digestion and nutrient absorption, particularly for iron. These physiological advantages of PPG are reflected in superior postoperative nutritional outcomes, including better preserved hemoglobin and serum protein [8], a higher serum albumin level [40], greater postoperative body weight [57], and preservation of skeletal muscle mass and overall nutritional status [58] (Table 2). TABLE 2Summary of Nutritional Outcome after Pylorus‐Preserving Gastrectomy (PPG).CategoryAuthor (Year)Study PeriodNumber of CasesStudy designKey FindingsMain outcomes; N (%) or others p IncidenceLee HJ, et al. (2025)2015–2017 PPG 129 DG 127 Prospective Multicenter RCT Nutritional parameters Preserved in PPG PPG vs. DG Hb level +0.01 vs. −0.76 g/dL < 0.001 Protein level −0.15 vs. −0.35 g/dL 0.002Mao X, et al. (2020)1996–2019 PPG 1955 DG 2916 Meta‐analysis (one RCT and 20 non‐RCTs) Nutritional parameters; Preserved in PPG Hb level< 0.001Total protein level< 0.001Albumin level< 0.001Fujita J, et al. (2016)2009–2010 PPG 313 DG BI 909 Retrospective Body weight loss; Higher in DG BI Body weight loss −6.9% vs. −7.9% 0.052 (Marginal) Terayama M, et al. (2023)2005–2019 PPG 44 DG BI 88 Retrospective Nutritional parameters; Preserved in PPG Total protein level< 0.05 (for 5 years)Albumin level< 0.05 (for 1 year)%SMI< 0.05 (for 3 years)Abbreviations: Hb, hemoglobin; %SMI, skeletal muscle index percentage (postoperative SMI/preoperative SMI). Summary of Nutritional Outcome after Pylorus‐Preserving Gastrectomy (PPG). PPG 129 DG 127 Prospective Multicenter RCT Nutritional parameters Preserved in PPG Hb level +0.01 vs. −0.76 g/dL Protein level −0.15 vs. −0.35 g/dL PPG 1955 DG 2916 Meta‐analysis (one RCT and 20 non‐RCTs) Nutritional parameters; Preserved in PPG PPG 313 DG BI 909 Body weight loss; Higher in DG BI Body weight loss −6.9% vs. −7.9% 0.052 (Marginal) PPG 44 DG BI 88 Nutritional parameters; Preserved in PPG Abbreviations: Hb, hemoglobin; %SMI, skeletal muscle index percentage (postoperative SMI/preoperative SMI). Quality of Life (QoL) Several studies suggest improved postoperative quality of life after PPG, although this effect may be influenced by DGE. Questionnaire‐based assessments of postoperative QoL after PPG indicate meaningful benefits in various functional and symptom‐related domains. In a large‐scale investigation of 1 153 patients undergoing various types of gastrectomy, PPG demonstrated the lowest incidence of dumping syndrome [59]. A nationwide survey of 2 368 patients from 52 institutions using the Postgastrectomy Syndrome Assessment Scale‐45 (PGSAS‐45), a validated questionnaire assessing post‐gastrectomy symptoms and quality of life, demonstrated that PPG was associated with fewer dumping symptoms and less diarrhea compared with DG [57]. Consistently, PPG showed significantly better global, functional, and symptom scales than DG based on the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ‐C30) and Stomach Module 22 (EORTC QLQ‐STO22) [60]. In contrast, a recent observational study has reported no significant differences in postoperative body weight changes or overall QoL between PPG and DG [61], while a secondary analysis of a Korean RCT demonstrated that DGE, which occurs more frequently after PPG, adversely affects QoL [50] (Table 3). TABLE 3Summary of Quality of Life (QoL) Outcome after Pylorus‐Preserving Gastrectomy (PPG).CategoryAuthor (Year)Study PeriodNumber of CasesStudy designKey FindingsMain outcomes; N (%) or others p IncidenceMine S, et al. (2010)2007–2008 PPG 302 DG BI 173 DG RY 307 Retrospective Incidence of dumping syndrome; Lower in PPG PPG vs. DG BI vs. DB RY Early dumping 178 (58.9) vs. 120 (69.4) vs. 191 (62.2) < 0.001 Late dumping 81 (26.8) vs. 77 (44.5) vs. 110 (35.8) < 0.001Fujita J, et al. (2016)2009–2010 PPG 313 DG BI 909 Retrospective Subscales of PGSAS‐45; Better in PPG PPG vs. DG Dumping subscale 1.8 vs. 2.0 0.003 Diarrhea subscale 1.8 vs. 2.0 < 0.001 Necessity for additional meals 1.8 vs. 1.9 0.034Huang C, et al. (2020)2015–2017 PPG 40 DG BI 51 Retrospective EORTC QLQ‐C30 and STO22; Better in PPG Global and functional scales (spider graph)PPG, higher (better)Symptoms scales (spider graph)PPG, lower (better)Tanaka C, et al. (2025)2016–2019 PPG 29 DG 211 ➔ after PSM, PPG 25, DG 25 Retrospective EORTC QLQ‐C30 and PGSAS‐37; No differences Postoperative QOL and DGE N.S Rhee YS, et al. (2025)2015–2017 PPG 124; DGE 21 Non‐DGE 103 KLASS‐04 RCT secondary analysis EORTC QLQ‐C30; Worse in PPG with DGE Nausea and vomiting scale (Generalized linear mixed models) 0.004 Constipation scale (Generalized linear mixed models) 0.04Abbreviations: EORTC QLQ‐STO22, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Stomach Module 22; EORTC QLQ‐C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30; PGSAS‐45, Postgastrectomy Syndrome Assessment Scale‐45; PSM, propensity score matching. Summary of Quality of Life (QoL) Outcome after Pylorus‐Preserving Gastrectomy (PPG). PPG 302 DG BI 173 DG RY 307 Incidence of dumping syndrome; Lower in PPG Early dumping 178 (58.9) vs. 120 (69.4) vs. 191 (62.2) Late dumping 81 (26.8) vs. 77 (44.5) vs. 110 (35.8) PPG 313 DG BI 909 Subscales of PGSAS‐45; Better in PPG Dumping subscale 1.8 vs. 2.0 Diarrhea subscale 1.8 vs. 2.0 Necessity for additional meals 1.8 vs. 1.9 PPG 40 DG BI 51 EORTC QLQ‐C30 and STO22; Better in PPG PPG 29 DG 211 ➔ after PSM, PPG 25, DG 25 EORTC QLQ‐C30 and PGSAS‐37; No differences PPG 124; DGE 21 Non‐DGE 103 EORTC QLQ‐C30; Worse in PPG with DGE Nausea and vomiting scale (Generalized linear mixed models) Constipation scale (Generalized linear mixed models) Abbreviations: EORTC QLQ‐STO22, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Stomach Module 22; EORTC QLQ‐C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30; PGSAS‐45, Postgastrectomy Syndrome Assessment Scale‐45; PSM, propensity score matching. Oncologic Outcomes of PPG: Feasibility in Advanced Gastric Cancer A systematic review encompassing 21 studies confirmed that PPG achieves comparable long‐term survival and recurrence rates to DG, despite its inherently limited lymphadenectomy, possibly owing to the omission of LN#5 dissection [40]. A Korean retrospective study of 701 patients undergoing curative TG or DG evaluated the oncological feasibility of middle‐segmental gastrectomy. After excluding cN2/N3 carcinomas, LN#5 metastasis was absent in all cT1–3 N0/1M0 cases, and LN#6 metastasis occurred in only 0.7% (4 out of 612) of patients, predominantly in those with advanced or large tumors. Based on these findings, middle‐segmental gastrectomy was safely suggested for carefully selected clinical EGC [23]. In addition, a Korean multicenter RCT, which included a small number of advanced cases (pT3/4a: PPG 2, DG 4; pN2/3: PPG 4, DG 6), showed no significant differences in overall survival (OS) or disease‐free survival (DFS) (p = 0.16 and 0.98, respectively), with only two recurrences [8]. Notably, a recent retrospective study evaluating the natural course of patients with pathologically confirmed LN#6 metastasis after PPG demonstrated that even patients with advanced disease, who were preoperatively understaged, achieved excellent DFS with standard adjuvant chemotherapy alone, without requiring completion gastrectomy or additional lymphadenectomy [10]. While the current evidence remains limited, accumulating data suggest the potential oncologic acceptability of PPG in carefully selected patients with more advanced disease, warranting cautious interpretation and further prospective validation. Randomized Controlled Trial Comparing PPG and DG To our knowledge, three prospective RCTs have directly compared PPG with DG in gastric cancer patients (Table 4). TABLE 4Prospective Randomized Controlled Trials (RCTs): Pylorus‐Preserving Gastrectomy (PPG) vs. Distal Gastrectomy (DG) in Early Gastric Cancer (EGC).Author (Year)Country/Study designStudy PeriodNumber of CasesOutcome parametersKey Findings N (%) or othersShibata C, et al. (2004) Japan Prospective Multicenter RCT 9 hospitals 1994–1996 Randomized 81; ITT; PPG 41 DG 40 PP; PPG 36 DG 38 Early outcomes PPG vs. DG Morbidity Mortality Morbidity 4 (11) vs. 4 (11) p > 0.05 Mortality 0 (0) Operative time Intraoperative blood loss Time until removal of the nasogastric tube Number of cases requiring reinsertion of the nasogastric tube Time until start of meal Postoperative hospital stay Postoperative body weight loss N.S Long‐term outcomes PPG vs. DG Early dumping syndrome 2/24 (8.3) vs. 7/21 (33.3) p = 0.037 Mean follow‐up duration Decrease in body weight Food intake (increased, no change, decreased) Overall satisfaction (satisfied, middle, unsatisfied) Hemoglobin Total protein N.S Lee HJ, et al. (KLASS‐04, 2025) Korea Prospective Multicenter RCT 9 hospitals 2015–2017 Randomized 256; ITT; PPG 129 DG 127 PP; PPG 107 DG 108 Primary endpoint PPG vs. DG Dumping at 1 year (Sigstad score, 7 or more) 16 (13.2) vs. 19 (15.8) p = 0.622 Secondary endpoints PPG vs. DG Short‐term complications Pyloric stenosis (DGE) 7 (5.4) vs. 1 (0.8) p = 0.014 Overall morbidity Complications except pyloric stenosis (DGE) Postoperative hospital stay Readmission within 30 days Reoperation within 90 days Mortality within 90 days N.S Long‐term complications for 3 years 3‐year OS and DFS 3‐year OS, p = 0.98 3‐year DFS, p = 0.16 Incidence of gallbladder stone 2.33% vs. 8.66% p = 0.026 Changes in body weight, fat volume, and other nutritional parameters Hb level +0.01 vs. −0.76 g/dL p < 0.001 Protein level −0.15 vs. −0.35 g/dL p = 0.002 Gastroscopic findings (gastritis, bile reflux, gastric emptying, reflux esophagitis, marginal ulcer) DGE grade IV 16.3% vs. 3.9% p = 0.001 Reflux esophagitis 17.8% vs. 6.3% p = 0.005 Quality of life N.S Xia X, et al. (2025) China Prospective Single center RCT 2017–2019 Randomized 100; PPG 50 DG 50 Analysis for, PPG 44 DG 44 Primary endpoint PPG vs. DG 5‐year DFS p = 0.46 Secondary endpoints PPG vs. DG 5‐year OS p = 0.64Postoperative complications DGE 4 (9.1) vs. 2 (4.5) p = 0.398 Gallbladder emptying rate (%) 33.7 vs. 26.1 p = 0.015 Time to half gastric emptying (minutes) 108.0 vs. 93.4 p = 0.033 Retention at 120 min of stomach (%) 48.8 vs. 39.8 p = 0.048 Quality of life Nausea and vomiting; better in DG Appetite and reflux; better in PPG Abbreviations: DFS, disease‐free survival; ITT, intention‐to‐treat; N.S., not significant; OS, overall survival; PP, per‐protocol. Prospective Randomized Controlled Trials (RCTs): Pylorus‐Preserving Gastrectomy (PPG) vs. Distal Gastrectomy (DG) in Early Gastric Cancer (EGC). Japan Prospective Multicenter RCT 9 hospitals Randomized 81; ITT; PPG 41 DG 40 PP; PPG 36 DG 38 Morbidity Mortality Morbidity 4 (11) vs. 4 (11) p > 0.05 Mortality 0 (0) Operative time Intraoperative blood loss Time until removal of the nasogastric tube Number of cases requiring reinsertion of the nasogastric tube Time until start of meal Postoperative hospital stay Postoperative body weight loss Early dumping syndrome 2/24 (8.3) vs. 7/21 (33.3) p = 0.037 Mean follow‐up duration Decrease in body weight Food intake (increased, no change, decreased) Overall satisfaction (satisfied, middle, unsatisfied) Hemoglobin Total protein Korea Prospective Multicenter RCT 9 hospitals Randomized 256; ITT; PPG 129 DG 127 PP; PPG 107 DG 108 16 (13.2) vs. 19 (15.8) p = 0.622 Pyloric stenosis (DGE) 7 (5.4) vs. 1 (0.8) p = 0.014 Overall morbidity Complications except pyloric stenosis (DGE) Postoperative hospital stay Readmission within 30 days Reoperation within 90 days Mortality within 90 days 3‐year OS and DFS 3‐year OS, p = 0.98 3‐year DFS, p = 0.16 Incidence of gallbladder stone 2.33% vs. 8.66% p = 0.026 Changes in body weight, fat volume, and other nutritional parameters Hb level +0.01 vs. −0.76 g/dL p < 0.001 Protein level −0.15 vs. −0.35 g/dL p = 0.002 Gastroscopic findings (gastritis, bile reflux, gastric emptying, reflux esophagitis, marginal ulcer) DGE grade IV 16.3% vs. 3.9% p = 0.001 Reflux esophagitis 17.8% vs. 6.3% p = 0.005 China Prospective Single center RCT Randomized 100; PPG 50 DG 50 Analysis for, PPG 44 DG 44 DGE 4 (9.1) vs. 2 (4.5) p = 0.398 Gallbladder emptying rate (%) 33.7 vs. 26.1 p = 0.015 Time to half gastric emptying (minutes) 108.0 vs. 93.4 p = 0.033 Retention at 120 min of stomach (%) 48.8 vs. 39.8 p = 0.048 Nausea and vomiting; better in DG Appetite and reflux; better in PPG Abbreviations: DFS, disease‐free survival; ITT, intention‐to‐treat; N.S., not significant; OS, overall survival; PP, per‐protocol. The earliest prospective multicenter RCT conducted in Japan randomized 81 patients with cT1N0M0 EGC to undergo either PPG or DG with Billroth I reconstruction. Early surgical outcomes, including operative time, blood loss, postoperative morbidity, and mortality, were comparable between the two groups. In terms of long‐term outcomes, the incidence of dumping syndrome was significantly lower after PPG (p = 0.037) [6]. The Korean multicenter prospective RCT (KLASS‐04) enrolled 256 patients with cT1N0M0 EGC to undergo either laparoscopic PPG or laparoscopic DG. The primary endpoint, dumping symptoms at one year, showed no significant difference between the two groups (13.2 vs. 15.8%). PPG was associated with significantly less gallstone formation (p = 0.026) and better preservation of hemoglobin and total protein levels compared to DG (p < 0.001 and p = 0.002, respectively). However, grade IV DGE and reflux esophagitis were more frequent after PPG (p = 0.005 and p = 0.001, respectively) [8]. The most recent prospective single‐center RCT conducted in China randomized 88 patients with clinical and pathological T1N0M0 EGC to undergo either laparoscopic‐assisted PPG or laparoscopic‐assisted DG. DFS and OS were equivalent at 5 years (p = 0.46 and 0.64). In terms of functional outcomes, the gallbladder emptying rate was significantly higher after PPG (p = 0.015). Although the incidence of DGE was not significantly different (p = 0.398), gastric emptying scintigraphy after PPG demonstrated a longer time for half gastric emptying (p = 0.033) and greater gastric retention at 120 min (p = 0.048), indicating delayed yet functionally preserved gastric emptying [9]. Collectively, these RCTs demonstrated that PPG provides comparable oncologic outcomes to DG with favorable functional and nutritional benefits. Integration of Robotic and Navigation‐Guided Surgery in PPG The technical capabilities of robotic platforms, including three‐dimensional magnified visualization, articulated instruments with enhanced dexterity, and tremor‐control technology, can facilitate greater precision in nerve and vessel preservation, along with oncologic thoroughness in PPG. A retrospective propensity score–matched analysis comparing robot‐assisted PPG and laparoscopy‐assisted PPG demonstrated no significant differences in postoperative complication rates or the number of retrieved lymph nodes [62]. Despite accumulating experience with robotic PPG [63], most comparative studies have focused on robotic vs. laparoscopic gastrectomy in general [64], and a direct comparison between robotic and laparoscopic PPG remains scarce. A Korean multicenter RCT comparing laparoscopic standard gastrectomy (LSG) with laparoscopic sentinel node navigation surgery (LSNNS), a technique that identifies sentinel lymph nodes to guide selective lymphadenectomy and facilitate function‐preserving surgery [65], demonstrated that LSNNS achieved comparable short‐ and long‐term outcomes, including 30‐day complications, 5‐year DFS, disease‐specific survival (DSS), and OS [66], along with superior QoL and nutritional results [67]. Notably, in the per‐protocol analysis, segmental gastrectomy cases included within the LSNNS cohort demonstrated acceptable oncologic safety (17 out of 198 patients). Given the morphological similarity of PPG to segmental gastrectomy, these findings support the potential applicability of navigation‐guided visualization to PPG, enabling tailored lymphadenectomy while maintaining oncologic safety [68]. Integration of robotic precision and navigation‐guided surgery may redefine the technical boundaries of PPG, potentially broadening its application beyond traditional indications. Conclusion Given accumulating evidence from randomized and observational studies in East Asia, PPG has been widely adopted as a standard curative surgical option for patients with cT1N0M0 EGC, with favorable postoperative outcomes compared with DG. These advantages include reduced postoperative symptoms, improved nutritional preservation, and better quality of life, although delayed gastric emptying remains an important functional concern. Accumulating data further suggests that PPG may be oncologically acceptable for carefully selected patients with advanced diseases. Advances in minimally invasive robotic platforms and navigation‐guided surgery enable precise and tailored surgery, thereby broadening the application of PPG beyond its traditional indications. As most of the existing evidence originates from Eastern populations [69], the generalizability of current findings remains limited. Future investigations involving geographically and demographically diverse cohorts are required to clarify the broader applicability of PPG. Author Contributions Hyuk‐Joon Lee: conceptualization, supervision, drafting, review and editing. Sa‐Hong Kim: data curation, visualization, original drafting. All Authors: Final approval of the manuscript. Funding No funding was received for this study. Ethics Statement The authors have nothing to report. Consent The authors have nothing to report. Conflicts of Interest The authors declare no conflicts of interest.